Xeris BiopharmaXERS
那斯達克 · USD
5.18
+0.09
(+1.77%)
盤中 08/02 01:06 (UTC+8)
08/02 01:06 (UTC+8)
Xeris BiopharmaXERS
5.18
+0.09
(+1.77%)
財務數據
損益表
- 0.33
- 0.33
- 0.38
- 0.48
- 0.44
- 0.41
- 0.48
- 0.54
- 0.60
- 0.60
- 11.50
- 0.16
- 14.50
- 27.13
- -8.13
- -8.45
- 18.28
- 12.91
- 10.74
- 0.03
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 60,119 | 60,099 | 54,268 | 48,065 | 40,638 | 44,390 | 48,320 | 38,008 | 33,196 | 33,144 |
營業成本 | 8,728 | 9,478 | 13,593 | 7,790 | 5,971 | 7,570 | 8,201 | 7,555 | 5,319 | 6,291 |
營業毛利 | 51,391 | 50,621 | 40,675 | 40,275 | 34,667 | 36,820 | 40,119 | 30,453 | 27,877 | 26,853 |
營業費用 | 54,481 | 48,942 | 53,568 | 48,462 | - | 46,661 | 45,032 | 46,432 | 41,154 | 42,023 |
研發費用 | 7,753 | 6,092 | 5,888 | 5,759 | 7,821 | 6,382 | 5,034 | 6,087 | 4,838 | 4,955 |
推銷及管理費用 | 44,018 | 40,139 | 44,969 | 39,993 | 38,380 | 37,568 | 37,287 | 37,635 | 33,605 | 34,357 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 2,710 | 2,711 | 2,711 | 2,710 | 2,711 | 2,711 | 2,711 | 2,710 | 2,711 | 2,711 |
營業利益 | -3,090 | 1,679 | -12,893 | -8,187 | -14,245 | -9,841 | -4,913 | -15,979 | -13,277 | -15,170 |
其他收入及費用 | 1,175 | 911 | 1,617 | 1,895 | 2,604 | 3,233 | -767 | 1,990 | 2,659 | 7,492 |
利息費用 | 7,305 | 7,703 | 7,786 | 7,964 | 7,032 | 7,018 | 6,847 | 6,528 | 6,216 | 5,590 |
稅前純益 | -9,220 | -5,113 | -19,062 | -14,256 | -18,673 | -13,626 | -12,527 | -20,517 | -16,834 | -13,268 |
所得稅 | - | - | -3,324 | 749 | 307 | -236 | -338 | -675 | - | -338 |
稅後純益 | -9,220 | -5,113 | -15,738 | -15,005 | -18,980 | -13,390 | -12,189 | -19,842 | -16,834 | -12,930 |
基本每股稅後盈餘(元) | -0.06 | -0.02 | -0.11 | -0.10 | -0.14 | - | -0.09 | -0.14 | -0.12 | -0.10 |
稀釋每股稅後盈餘(元) | -0.06 | -0.03 | -0.10 | -0.10 | -0.14 | -0.09 | -0.09 | -0.15 | -0.12 | -0.10 |
基本平均股數(千股) | 152445.00 | 149240.00 | 148993.00 | 148345.00 | 140513.00 | - | 138059.00 | 137338.00 | 137142.00 | 135986.00 |
稀釋平均股數(千股) | 152445.00 | 149240.00 | 148993.00 | 148345.00 | 140513.00 | - | 138059.00 | 137338.00 | 137142.00 | 135986.00 |
還原基本每股稅後盈餘(元) | -0.06 | -0.02 | -0.11 | -0.10 | -0.14 | - | -0.09 | -0.14 | -0.12 | -0.10 |
還原稀釋每股稅後盈餘(元) | -0.06 | -0.03 | -0.10 | -0.10 | -0.14 | -0.09 | -0.09 | -0.15 | -0.12 | -0.10 |
還原基本平均股數(千股) | 152,445 | 149,240 | 148,993 | 148,345 | 140,513 | - | 138,059 | 137,338 | 137,142 | 135,986 |
還原稀釋平均股數(千股) | 152,445 | 149,240 | 148,993 | 148,345 | 140,513 | - | 138,059 | 137,338 | 137,142 | 135,986 |
EBITDA(千元) | 2,072 | 6,474 | -7,541 | -2,629 | -8,038 | -2,968 | -2,057 | -10,497 | -7,271 | -3,691 |